Bruker Corp’s chief accounting officer buys $23,697 in stock

Published 11/03/2025, 21:14
Bruker Corp’s chief accounting officer buys $23,697 in stock

Thomas Bures, the Chief Accounting Officer of Bruker Corp (NASDAQ:BRKR), recently acquired 500 shares of the company’s common stock. The transaction, which took place on March 10, 2025, was valued at approximately $23,697, with each share priced at $47.395. The purchase comes as the stock trades near its 52-week low of $45.29, despite the company’s strong 13.56% revenue growth over the last twelve months.

Following this purchase, Bures now holds a total of 3,472 shares in Bruker Corp. The acquisition was conducted through direct ownership. According to InvestingPro analysis, Bruker appears undervalued, with analyst price targets ranging from $55 to $80.

Bruker Corp, based in Billerica, Massachusetts, specializes in laboratory analytical instruments, and this transaction reflects continued insider confidence in the company’s performance. The $6.92 billion market cap company is expected to see net income growth this year, according to InvestingPro, which offers comprehensive analysis and 6 additional key insights in its Pro Research Report.

In other recent news, Bruker Corporation reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. The company’s revenue also exceeded projections, reaching $979.6 million compared to the expected $962.38 million, marking a 14.6% year-over-year increase. Bruker has also announced significant advancements in proteomics technology, including the introduction of the Athena Ion Processor on the timsTOF Ultra 2 system, expected to improve protein group identification and peptide identifications significantly. Additionally, Bruker has integrated DeutEx™ software to enhance the study of proteins, reflecting the company’s commitment to supporting innovations in life sciences. The company has further expanded its board by appointing Laura Francis as an independent director, bringing her extensive experience in the medtech and life science tools industries. In product news, Bruker launched the X4 POSEIDON, a new 3D X-ray microscope system designed to offer high-resolution imaging capabilities. These developments illustrate Bruker’s ongoing efforts to advance its technological offerings and strengthen its leadership team.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.